March 26, 2018 / 10:49 AM / 24 days ago

BRIEF-Bayer: Rolling Submission Of New Drug Application In US For Larotrectinib Completed

March 26 (Reuters) - BAYER AG:

* ‍ANNOUNCES COMPLETION OF ROLLING SUBMISSION OF NEW DRUG APPLICATION IN U.S. FOR LAROTRECTINIB FOR TREATMENT OF TRK FUSION CANCER​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below